Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Minerva Anestesiologica
|
February 20, 2013
Why hyperoxia matters during acute anemia
P Lauscher, V Mirakaj, K Koenig, et al.
Acta Physiologica (Oxford, England)
|
September 3, 2011
Effects of hyperoxic ventilation on 6-h survival at the critical haemoglobin concentration aggravated by experimentally induced tachycardia in anaesthetized pigs
H Kertscho, P Lauscher, L Raab, et al.
Minerva Anestesiologica
|
September 29, 2011
Changes in heart rate variability across different degrees of acute dilutional anemia
P Lauscher, H Kertscho, L Raab, et al.
British Journal of Anaesthesia
|
December 14, 2011
Effects of alterations of inspiratory oxygen fractions on heart rate variability
P Lauscher, H Kertscho, P Enselmann, et al.
HIV Medicine
|
July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years
I Krznaric, M Bickel, A Carganico, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Minerva Anestesiologica
|
February 20, 2013
Why hyperoxia matters during acute anemia
P Lauscher, V Mirakaj, K Koenig, et al.
Acta Physiologica (Oxford, England)
|
September 3, 2011
Effects of hyperoxic ventilation on 6-h survival at the critical haemoglobin concentration aggravated by experimentally induced tachycardia in anaesthetized pigs
H Kertscho, P Lauscher, L Raab, et al.
Minerva Anestesiologica
|
September 29, 2011
Changes in heart rate variability across different degrees of acute dilutional anemia
P Lauscher, H Kertscho, L Raab, et al.
British Journal of Anaesthesia
|
December 14, 2011
Effects of alterations of inspiratory oxygen fractions on heart rate variability
P Lauscher, H Kertscho, P Enselmann, et al.
HIV Medicine
|
July 5, 2018
Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years
I Krznaric, M Bickel, A Carganico, et al.
Page
of 1